What is the ALS Functional Rating Scale (ALSFRS-R)?
At a Glance
The ALSFRS-R is a 12-item questionnaire that measures physical function in ALS patients, with scores ranging from 0 to 48. Doctors focus on your rate of change over time, rather than a single score, to track disease progression and proactively plan for supportive care and assistive devices.
The ALS Functional Rating Scale-Revised (ALSFRS-R) is a 12-item questionnaire used by medical professionals to measure physical function and track disease progression in people with amyotrophic lateral sclerosis (ALS) [1]. It is usually administered by a nurse or doctor during a clinic visit, though sometimes patients self-report their scores through an app or online portal [2][3]. The total score ranges from 0 to 48, where a higher score indicates greater preserved physical ability [4]. Rather than focusing on a single number from one visit, doctors pay the most attention to your rate of change—how many points your score drops over weeks or months [5][6]. This rate of decline helps your care team understand your unique disease trajectory and anticipate when you might benefit from new supportive treatments to maintain your quality of life [7][8].
What Does the ALSFRS-R Measure?
The questionnaire evaluates twelve specific daily activities, which are grouped into four main functional categories [9]. You or your doctor will rate each activity on a scale from 0 to 4 [4]. A score of 4 means normal function. While a score of 0 indicates a total loss of function for that specific task, it is important to remember that this score is a signal for your medical team to provide supportive interventions—like mobility aids or communication devices—so you are never left helpless [8].
The four categories and their corresponding items are:
- Bulbar Function (Head and Neck): Measures your ability to speak clearly, swallow food and liquids, and manage saliva [9].
- Fine Motor Skills (Hands and Arms): Evaluates tasks requiring dexterity, including your ability to write, cut food, handle utensils, and manage dressing and personal hygiene [9]. (If you are experiencing slight weakness in your hands, you might notice your score in this section dropping slightly below a 4).
- Gross Motor Skills (Legs and Torso): Assesses larger movements, including walking, climbing stairs, and turning over or adjusting blankets in bed [9].
- Respiratory Function (Breathing): Checks for dyspnea (shortness of breath), orthopnea (shortness of breath when lying flat), and whether you need any external respiratory support or devices [9].
Why the “Rate of Change” Matters Most
ALS affects everyone differently, meaning there is no “normal” score [10]. Instead of comparing your score to others, your doctor uses your ALSFRS-R to compare you to your past self [5].
By calculating the rate of decline—often referred to as your “slope” or points lost per month—your medical team can better plan your future care [11][5]. On average, patients may see a decline of about 1 point per month, but individual progression varies widely [12]. Tracking this trajectory allows your team to proactively time interventions [7]. For example, if your bulbar subscore is dropping, they can intervene early with a feeding tube or communication device [8].
Nuances to Keep in Mind
- Subscores vs. Total Score: Because the total score adds everything together, it can sometimes mask important changes in a specific area [4]. You might have a stable total score but be experiencing a decline in breathing. Doctors must look at the specific subscores, not just the total [13].
- Plateaus Happen: While the score generally trends downward, progression is not perfectly smooth or linear [14]. Many patients experience plateaus where their score does not change for a time, or even minor score reversals [15][16].
- Day-to-Day Fluctuations: It is completely normal to feel anxious about taking this test, as facing potential physical decline carries a heavy emotional weight. Try to avoid hyper-fixating on self-tracking every single day. Having a “bad day” where your hand feels extra weak does not mean your permanent “slope” has suddenly worsened.
- Advanced Stages: In the later stages of ALS, the total ALSFRS-R score may become less useful for capturing your true quality of life, and doctors may rely on other specific measures [17].
Common questions in this guide
What is a normal ALSFRS-R score?
What does the ALSFRS-R questionnaire measure?
Why is the rate of change in my ALSFRS-R score important?
Can my ALSFRS-R score stay the same over time?
Should I track my ALSFRS-R score at home?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Tracking scores over time
How do doctors use my ALSFRS-R scores to track changes over time?
Subscores and total score
Would the subscores for breathing or swallowing be checked as well as my total score?
Support and equipment
What support might my medical team offer if a specific task score drops?
Related questions
Show more
Get notified when new evidence is published on Amyotrophic lateral sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
Smith RA, Macklin EA, Myers KJ, et al.
European journal of neurology 2018; (25(7)):907-e66 doi:10.1111/ene.13638.
PMID: 29577526 - 2
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data capture.
Steinfurth L, Grehl T, Weyen U, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(5-6)):495-506 doi:10.1080/21678421.2025.2468404.
PMID: 39985291 - 3
Stay at home with the amyotrophic lateral sclerosis functional rating scale.
McDermott CJ
Journal of neurology, neurosurgery, and psychiatry 2020; (91(1)):7 doi:10.1136/jnnp-2019-321707.
PMID: 31558652 - 4
What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
Rooney J, Burke T, Vajda A, et al.
Journal of neurology, neurosurgery, and psychiatry 2017; (88(5)):381-385 doi:10.1136/jnnp-2016-314661.
PMID: 27888187 - 5
Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States.
Engelberg-Cook E, Shah JS, Teixeira da Silva Hucke A, et al.
Mayo Clinic proceedings. Innovations, quality & outcomes 2024; (8(5)):482-492 doi:10.1016/j.mayocpiqo.2024.07.008.
PMID: 39323877 - 6
Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study.
van Eijk RPA, Weemering DN, Opie-Martin S, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(sup1)):30-40 doi:10.1080/21678421.2024.2443985.
PMID: 40326917 - 7
Predictive modeling of ALS progression: an XGBoost approach using clinical features.
Gupta R, Bhandari M, Grover A, et al.
BioData mining 2024; (17(1)):54 doi:10.1186/s13040-024-00399-5.
PMID: 39623504 - 8
Variation in assistive technology use in Motor Neuron Disease according to clinical phenotypes and ALS Functional Rating Scale - Revised Score: A prospective observational study.
Connors K, Mahony L, Morgan P
NeuroRehabilitation 2019; (44(2)):303-313 doi:10.3233/NRE-182511.
PMID: 31006691 - 9
Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
Mehdipour A, Teshler L, Dal Bello-Haas V, et al.
Physical therapy 2023; (103(11)) doi:10.1093/ptj/pzad109.
PMID: 37581600 - 10
Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns.
M Amaral D, Soares DF, Gromicho M, et al.
Nature communications 2024; (15(1)):5717 doi:10.1038/s41467-024-49954-y.
PMID: 38977678 - 11
Associations between urate levels and amyotrophic lateral sclerosis functional score with edaravone treatment: Post hoc analysis of studies MCI186-16, MCI186-17, and MCI186-19.
Takahashi F, Kano O, Nagano Y, et al.
Muscle & nerve 2022; (66(5)):583-592 doi:10.1002/mus.27699.
PMID: 36054038 - 12
Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.
Ludolph AC, Corcia P, Desnuelle C, et al.
Muscle & nerve 2024; (70(1)):36-41 doi:10.1002/mus.28101.
PMID: 38712849 - 13
An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials.
van Eijk RPA, de Jongh AD, Nikolakopoulos S, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2021; (22(3-4)):300-307 doi:10.1080/21678421.2021.1879865.
PMID: 33527843 - 14
Clinimetrics: Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R).
Lee M, McCambridge A
Journal of physiotherapy 2018; (64(4)):269-270 doi:10.1016/j.jphys.2018.07.005.
PMID: 30193742 - 15
Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis.
Hu N, Shen D, Yang X, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022; (97()):93-98 doi:10.1016/j.jocn.2022.01.016.
PMID: 35074582 - 16
The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study.
Hu N, Shen D, Yang X, et al.
Acta neurologica Belgica 2022; (122(6)):1567-1573 doi:10.1007/s13760-021-01849-1.
PMID: 35034333 - 17
Evaluating ALSFRS-R as an indicator of disease milestones and functional independence: An observational study of US neurologists and their patients with amyotrophic lateral sclerosis.
Mehdiyoun NF, Wright J, Robinson RL, et al.
Journal of the neurological sciences 2026; (481()):125732 doi:10.1016/j.jns.2026.125732.
PMID: 41520654
This page is for informational purposes only and does not replace professional medical advice. Always discuss your ALSFRS-R score and disease progression with your neurologist or ALS care team.